Search Articles — Sudonull

Search Results

In this project

Compiler from scratch: lexer parser type inference

https://sudonull.com/compiler-from-scratch-lexer-parser-type-inference

Experience creating a compiler for my own language: from lexer to LLVM IR. Handling generics, lambdas, linking. For middle/senior developers. Learn approaches without deep knowledge.

Secure file upload in Go: 7 attacks

https://sudonull.com/secure-file-upload-in-go-7-attacks

Analysis of 7 attacks on file upload in Go: type spoofing, DoS, path traversal, SSRF. Crypto-identification ECDSA, magic bytes, MaxBytesReader. For middle/senior dev.

Reflection in Unreal Engine: how the type system works

https://sudonull.com/reflection-in-unreal-engine-how-the-type-system-works

Get to know the Unreal Engine reflection system: code generation, UObject and FField hierarchies, runtime data access. For C++ developers.

From other projects

Tzield approved for children from 1 year: delaying type 1 diabetes

https://ymaho.com/tzield-approved-for-children-from-1-year-delaying-type-1-diabetes

FDA expanded indications for teplizumab to children from one year. First drug capable of delaying diabetes for years at the preclinical stage. Learn how infusions change the prognosis for infants.

Death of foundation: why the beauty market is in panic

https://ymaho.com/death-of-foundation-why-the-beauty-market-is-in-panic

Sales of tinting products soared by 89%, but this is a crash, not a success. We analyze the economy, the war for technology, and the new type of consumer. Find out who will survive.

Crisis of the Strait of Hormuz: the global economy in 2026

https://ymaho.com/crisis-of-the-strait-of-hormuz-the-global-economy-in-2026

How the paralysis of the Strait of Hormuz triggered an uncontrollable collapse of global supply chains and why central banks have no tools for a new type of crisis. Full analysis and forecast.

Teplizumab approved for children: delaying type 1 diabetes

https://ymaho.com/teplizumab-approved-for-children-delaying-type-1-diabetes

FDA approved teplizumab for children from 1 year old. Learn how disease-modifying therapy changes the treatment paradigm for type 1 diabetes. Detailed analysis.

Trending Now